My watch list
my.bionity.com  
Login  

PharmaFrontiers



PharmaFrontiers NASDAQ: PFTRis a commercialization-driven biotechnology company that develops autologous cellular therapies for the treatment of multiple sclerosis, congestive heart failure, and diabetes. The company is focused on autologous cellular therapy applications based on its proprietary stem cell and T cell vaccination technologies.

Additional recommended knowledge

Key products and research include:

Location of Operation

PharmaFrontiers is located in The Woodlands,Texas 30 miles north of Houston,Texas The company is located in a 10,200 sq. ft. facility is located on 3 acres in The Woodlands. This location provides space for pipeline development through R & D; a specialized flow cytometry and microscopy lab; support of clinical trials with GMP manufacturing Suites; Quality Systems management with Quality Control Laboratory, Regulatory Affairs, Quality Assurance; as well as administrative support space.

 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "PharmaFrontiers". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE